Glenmark Pharmaceuticals Ltd

NSE: GLENMARK BSE: 532296

₹2419.20

(0.17%)

Sun, 20 Sept 2026, 09:42 pm

MTF 5xInvest in Glenmark Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)68213.71

PE Ratio37.98

Dividend0.21

Health Technology

Pharmaceuticals: Major

24.5K

Glenmark Pharmaceuticals News

Glenmark AGM: Dividend, Financials Approved

Glenmark Pharmaceuticals shareholders approved FY26 financials and a ₹2.50 dividend at the 48th AGM. Mrs. Blanche Saldanha was reappointed as a Non-Executive Director.

11 Sept 2026

companies

Glenmark launches RYALTRIS Nasal Spray in Brazil

Glenmark Pharmaceuticals expands its global respiratory innovation footprint with the launch of RYALTRIS Nasal Spray in Brazil. The dual-action therapy treats allergic rhinitis symptoms in adults and adolescents, following ANVISA approval.

11 Sept 2026

companies

Glenmark Pharma Q1 Results: Net Profit Surges to ₹4.83B

Glenmark Pharmaceuticals reports Q1 consolidated net profit of ₹4.83B rupees vs ₹469M YoY, with revenue rising to ₹40.2B and EBITDA margin expanding to 19.51%.

31 Jul 2026

companies

Glenmark launches Sugammadex in US

Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, targeting a $1.6 billion market. The generic is bioequivalent to Merck's BRIDION.

28 Jul 2026

companies

Glenmark Pharma Eyes 70% Revenue From Innovative Drugs

Glenmark Pharma expects 70% of its revenue to come from innovative drugs within 5-6 years, signalling a strategic shift toward an innovation-based business model.

22 Jul 2026

companies

Showing 1–5 of 90

Rows per page:

Market Current News

Multi Commodity Exchange plans analyst meet on Sep 24

Multi Commodity Exchange of India has scheduled a meeting with analysts and investors on September 24.

18 Sept 2026

commodities

Axiom Gas Engineering IPO Day 1: Subscription at 0.61x

Axiom Gas Engineering IPO opens on Day 1 with a total subscription of 0.61x. QIBs lead at 0.80x, while Retail stands at 0.63x. Check full category-wise breakdown and offer details.

18 Sept 2026

ipo

India raises sugar stock limit for bulk buyers

The Indian government has doubled the stockholding limit for bulk sugar buyers from 15 to 30 days. The move aims to stabilize supply chains. Traders are also urged to pass on price savings to consumers.

18 Sept 2026

commodities

Elevate Campuses IPO: ₹1,850 Cr Issue

Elevate Campuses files DRHP for ₹1,850 crore IPO to fund K-12 acquisitions and debt repayment. The student housing leader reports ₹806.93 crore FY26 revenue.

18 Sept 2026

ipo

Swastika Infra IPO DRHP: ₹129 Cr Fresh Issue

Swastika Infra files DRHP for ₹129 crore fresh issue. The EPC firm reports ₹503.57 crore revenue in FY26 with 55% CAGR. Funds to meet working capital needs.

18 Sept 2026

ipo

Showing 1–5 of 94305

Rows per page: